CME Group Inc.
305.71USD
-0.2700 (-0.09%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CME.
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,737 | 1,706 | 1,880 | 1,649 | 1,538 | 1,692 | 1,642 | 1,525 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | 1,141 | 1,107 | 1,310 | 1,020 | 973 | 1,129 | 1,108 | 947 |
| Net Income | 1,037 | 1,042 | 1,154 | 1,183 | 908 | 1,025 | 956 | 875 |
| EPS (Diluted) | $2.89 | $2.88 | $3.18 | $3.24 | $2.49 | $2.81 | $2.62 | $2.40 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)